Home » Topics » Regulatory » Patents

Patents
RSS

Pfizer develops ACAT inhibitors

March 5, 1997

Zeneca reports cell adhesion inhibitors

March 4, 1997

Novel class of immunosuppressants disclosed by Novartis

March 4, 1997

Cephalosporin antibiotics revealed by Microcide

March 4, 1997

TK inhibitors disclosed by Pfizer

March 4, 1997

Antiarrhythmic agents reported by National Science Council

March 4, 1997

Takeda describes antitumor agents

March 4, 1997

RCT discloses compounds for radiolabeling leukocytes/lymphocytes

March 4, 1997

Novel polyamines fromTeva

March 3, 1997

Novel antitumor agents disclosed by Yale University

March 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...